文献速递泌尿生殖腹部MR

基于MRI和临床特征预测前列腺癌进展风险的深度学习模型的开发与验证

Development and Validation of a Deep Learning Model Based on MRI and Clinical Characteristics to Predict Risk of Prostate Cancer Progression.
PubMed 文献 · Radiol Imaging Cancer · 2025-01-01

这项回顾性研究纳入1143例男性患者的1607次MRI扫描,开发基于基线MRI和临床参数的深度学习模型预测临床显著前列腺癌进展时间。模型在内部和外部测试中均能预测进展,内部测试C指数0.68优于ERSPC和PCPT计算器(均P < .001),外部测试C指数0.56,可识别约20%低风险亚组。

要点

  • 深度学习模型基于基线MRI和临床参数预测临床显著前列腺癌进展,内部测试C指数0.68,外部测试0.56。
  • 模型可识别约20%的患者亚组,其1年、2年、4年随访后临床显著前列腺癌风险分别≤3%、≤8%、≤18%。
  • 内部测试中模型预测性能优于ERSPC和PCPT风险计算器(均P < .001)。

核心结论

  • 深度学习模型能准确预测前列腺癌进展并提供改进的风险估计,显示其有助于低风险前列腺癌的个性化随访。

研究设计与样本

  • 回顾性研究,纳入1143例男性患者的1607次MRI扫描(中位年龄64岁,IQR 59-68岁),2012年1月至2022年5月因怀疑临床显著前列腺癌行MRI且基线MRI阴性;开发基于基线MRI和临床参数(年龄、PSA水平、PSA密度、前列腺体积)的深度学习模型预测前列腺癌进展时间,进行内部和外部测试,采用Cox回归分析和Harrell C指数评估。

诊断标准与关键数值

  • 深度学习评分预测临床显著前列腺癌进展:内部队列HR 1.97(95% CI: 1.61, 2.41; P < .001),外部队列HR 1.32(95% CI: 1.14, 1.55; P < .001);模型识别约20%患者亚组,1年、2年、4年随访后临床显著前列腺癌风险分别≤3%、≤8%、≤18%;内部测试C指数0.68(95% CI: 0.63, 0.74),外部测试0.56(95% CI: 0.51, 0.61)。

临床应用与阅片要点

  • 深度学习模型基于基线MRI和临床参数预测临床显著前列腺癌进展,内部测试中C指数0.68优于ERSPC和PCPT计算器(均P < .001),外部测试C指数0.56;模型可识别约20%低风险亚组(1年、2年、4年风险分别≤3%、≤8%、≤18%),可能有助于个性化随访。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To validate a deep learning (DL) model for predicting the risk of prostate cancer (PCa) progression based on MRI and clinical parameters and compare it with established models. Materials and Methods This retrospective study included 1607 MRI scans of 1143 male patients (median age, 64 years; IQR, 59-68 years) undergoing MRI for suspicion of clinically significant PCa (csPCa) (International Society of Urological Pathology grade > 1) between January 2012 and May 2022 who were negative for csPCa at baseline MRI. A DL model was developed using baseline MRI and clinical parameters (age, prostate-specific antigen [PSA] level, PSA density, and prostate volume) to predict the time to PCa progression (defined as csPCa diagnosis at follow-up). Internal and external testing was performed. The model's ability to predict progression to csPCa was assessed by Cox regression analyses. Predictive performance of the DL model up to 5 years after baseline MRI in comparison with the European Randomized Study of Screening for Prostate Cancer (ERSPC) future-risk calculator, Prostate Cancer Prevention Trial (PCPT) risk calculator, and Prostate Imaging Reporting and Data System (PI-RADS) was assessed using the Harrell C-index. Optimized follow-up intervals were derived from Kaplan-Meier curves. Results DL scores predicted csPCa progression (internal cohort: hazard ratio [HR], 1.97 [95% CI: 1.61, 2.41; P < .001]; external cohort: HR, 1.32 [95% CI: 1.14, 1.55; P < .001]). The model identified a subgroup of patients (approximately 20%) with risks for csPCa of 3% or less, 8% or less, and 18% or less after 1-, 2-, and 4-year follow-up, respectively. DL scores had a C-index of 0.68 (95% CI: 0.63, 0.74) at internal testing and 0.56 (95% CI: 0.51, 0.61) at external testing, outperforming ERSPC and PCPT (both P < .001) at internal testing. Conclusion The DL model accurately predicted PCa progression and provided improved risk estimations, demonstrating its ability to aid in personalized follow-up for low-risk PCa. Keywords: MRI, Prostate Cancer, Deep Learning Supplemental material is available for this article. ©RSNA, 2025.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Roest C, Kwee TC, de Jong IJ, et al. Development and Validation of a Deep Learning Model Based on MRI and Clinical Characteristics to Predict Risk of Prostate Cancer Progression. Radiol Imaging Cancer. 2025. PMID: 39792014. doi:10.1148/rycan.240078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。